The frequent overexpression of two or more anti-apoptotic BCL2 family members in DLBCL lines and patient samples [47] prevents targeting specific BCL2 family members across all DLBCL patients. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.